Knight Capital Group’s Teva Pharmaceuticals TEVA Stock Holding History

Knight Capital Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.09M	Buy	+27,700	New	+$1.08M	0.02%	944

Other funds holding TEVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Knight Capital Group's TEVA Position: Q2 2013 in Review

Knight Capital Group opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2013: 22,726 shares worth $891K. The stake represents 0.02% of the portfolio and ranks #1129 among its holdings.

744 funds tracked by Wall St. Rank hold TEVA as of Q2 2013.

Knight Capital Group held 22,726 shares of Teva Pharmaceuticals worth $891K as of Q2 2013.
Teva Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
Teva Pharmaceuticals made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #1129 holding.
744 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.